| Mrs Pamela Mae Pedersen, LADC | |
|
722 S Lincoln Ave, Suite 1, York, NE 68467-4216 | |
| (402) 362-6128 | |
| (402) 362-7012 |
| Full Name | Mrs Pamela Mae Pedersen |
|---|---|
| Gender | Female |
| Speciality | Counselor - Addiction (substance Use Disorder) |
| Location | 722 S Lincoln Ave, York, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114007259 | NPI | - | NPPES |
| 47052851509 | Medicaid | NE | |
| 47052851517 | Medicaid | NE | |
| 47052851582 | Medicaid | NE | |
| 85276 | Other | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | 326 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Pamela Mae Pedersen, LADC 71 Kuester Lake, Grand Island, NE 68801 Ph: (308) 382-5356 | Mrs Pamela Mae Pedersen, LADC 722 S Lincoln Ave, Suite 1, York, NE 68467-4216 Ph: (402) 362-6128 |
News Archive
Anacor Pharmaceuticals and GlaxoSmithKline PLC today announced that GSK has exercised its option to obtain an exclusive licence to develop and commercialise GSK2251052 (GSK '052), formerly known as AN3365. GSK '052 is a novel, systemic antibiotic derived from Anacor's boron chemistry platform.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced positive six month data from its double-blind placebo controlled Phase 2b study of PRX302 (study name: TRIUMPH) in patients with moderate to severe benign prostatic hyperplasia (BPH) a bothersome urologic condition that affects the quality of life of more than 50 million men worldwide.
A new study published on the preprint server medRxiv* in November 2020 reports some of the unique elements of COVID-19-induced CRS and how understanding these distinctive characteristics of the disease could help in formulating specific interventions and therapies.
Shuaiyi International New Resources Development Inc. ("Shuaiyi" or the "Company"), a leading nutraceutical company focusing on the advanced technology related to the development of engineered "Cordyceps Militaris" in China, today announced the closing of a private placement with a group of accredited investors, pursuant to which the Company issued 1 million shares of the Company's common stock at a purchase price of $2.50 per share, for an aggregate purchase price of $2.5 million.
› Verified 7 days ago
Diana Kretz, PLMHP Counselor Medicare: Not Enrolled in Medicare Practice Location: 2011 N Lincoln Ave, York, NE 68467 Phone: 308-381-7487 Fax: 308-381-2712 | |
Erika Jones, LIMHP Counselor Medicare: Medicare Enrolled Practice Location: 223 E 8th St, York, NE 68467 Phone: 402-710-0564 Fax: 833-382-0104 | |
Lindsey Marie Eckert, Counselor Medicare: Medicare Enrolled Practice Location: 822 N Lincoln Ave Ste A, York, NE 68467 Phone: 402-937-1590 | |
Mrs. Leslie Jane Deal, MSMFT, LIMHP Counselor Medicare: Not Enrolled in Medicare Practice Location: 214 W 6th St, Suite 4, York, NE 68467 Phone: 402-942-2918 Fax: 402-745-6005 | |
Holly Fuhr, LMHP Counselor Medicare: Not Enrolled in Medicare Practice Location: 2119 Division Ave, York, NE 68467 Phone: 402-632-3353 Fax: 402-363-7828 | |
Rebecca Rose Green, PROVISIONAL LICENSED Counselor Medicare: Not Enrolled in Medicare Practice Location: 722 So Lincoln Ave, Suite 1, York, NE 68467 Phone: 402-362-6128 Fax: 402-362-7012 |